Our technology consists of a family of small molecules. These Agilyte^TM compounds have been shown to increase the susceptibility of highly resistant strains of bacteria to antibiotics, thereby requiring the use of fewer antibiotics, for less time, to elicit an effect and impact the dispersion and inhibition of biofilms.

Agilytes^TM uniquely disable bacterial protection mechanisms resulting in enhanced antibiotic activity, disruption, and prevention of biofilms and mitigation of bacterial resistance.

Agilyte^TM compounds have been modified from a naturally occurring molecule found in a marine sponge which originally had been shown to have anti-biofilm properties.

These compounds have since shown to be effective in overcoming resistance in multiple pre-clinical studies against a wide variety of gram positive and gram-negative pathogens, including multi-drug resistant microbes.